content: <HTML>
  <HEAD>
  <TITLE>sv8</TITLE>
  </HEAD>
  <BODY bgcolor="#FFFFFF">
  <!-- PAGEBREAK -->
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  <DIV align="center" style="font-size: 10pt; margin-top: 0pt"><B>As filed with the Securities and Exchange
  Commission on November&nbsp;8, 2007</B>
  </DIV>
  
  
  <DIV align="right" style="font-size: 10pt; margin-top: 8pt"><B>Registration No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>
  </DIV>
  
  
  <DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
  <DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>
  
  
  
  
  
  
  <DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
  SECURITIES AND EXCHANGE COMMISSION</B>
  </DIV>
  
  <DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
  </DIV>
  
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
  </DIV>
  
  <DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM S-8</B>
  </DIV>
  
  
  <DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>REGISTRATION STATEMENT<BR>
  UNDER<BR>
  THE SECURITIES ACT OF 1933</B>
  </DIV>
  
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
  </DIV>
  
  <DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>Inverness Medical Innovations, Inc.</B>
  </DIV>
  
  <DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>
  
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="31%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="31%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="31%">&nbsp;</TD>
  </TR>
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom">
      <TD align="center" valign="top"><B>Delaware<BR></B>
  (State or other jurisdiction of <BR>
  incorporation or organization)
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top"><B>51 Sawyer Road, Suite&nbsp;200<BR>
  Waltham, Massachusetts 02453<BR>
  (781)&nbsp;647-3900</B><BR>
  (Address of Registrant&#146;s Principal<BR>
  Executive Offices)
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top"><B>04-3565120<BR></B>
  (I.R.S. Employer<BR>
  Identification No.)</TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>HemoSense, Inc. Amended and Restated 1997 Stock Plan<BR>
  HemoSense, Inc. 2005 Equity Incentive Plan</B><BR>
  (Full titles of the plans)
  </DIV>
  
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
  </DIV>
  
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Ron Zwanziger</B><BR>
  Chairman, Chief Executive Officer and President<BR>
  Inverness Medical Innovations, Inc.<BR>
  51 Sawyer Road, Suite&nbsp;200<BR>
  Waltham, Massachusetts 02453<BR>
  (781)&nbsp;647-3900
  </DIV>
  
  <DIV align="center" style="font-size: 8pt; margin-top: 6pt">(Name, address, including zip code, and telephone number,<BR>
  including area code, of agent for service)</DIV>
  
  
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
  </DIV>
  
  
  <DIV align="center" style="font-size: 10pt; margin-top: 8pt"><B>With a copy to:</B>
  </DIV>
  
  
  <DIV align="center" style="font-size: 10pt; margin-top: 8pt"><B>Jay McNamara, Esq.</B><BR>
  Senior Counsel, Corporate &#038; Finance<BR>
  Inverness Medical Innovations, Inc.<BR>
  51 Sawyer Road, Suite&nbsp;200<BR>
  Waltham, Massachusetts 02453<BR>
  (781)&nbsp;647-3900
  </DIV>
  
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>
  </DIV>
  
  
  <DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>CALCULATION OF REGISTRATION FEE</B>
  </DIV>
  
  <DIV align="center">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="1%">&nbsp;</TD>
      <TD width="46%">&nbsp;</TD>
      <TD width="2%">&nbsp;</TD><!-- VRule -->
      <TD width="2%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="7%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="2%">&nbsp;</TD><!-- VRule -->
      <TD width="2%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="7%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="2%">&nbsp;</TD><!-- VRule -->
      <TD width="2%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="7%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="2%">&nbsp;</TD><!-- VRule -->
      <TD width="2%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="7%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
  
      <TD width="1%">&nbsp;</TD>
  </TR><TR style="font-size: 1px" valign="bottom">
      <TD nowrap align="left" colspan="23" style="border-bottom: 3px double #000000">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
  
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Proposed</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Proposed</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
  
      <TD nowrap align="center"><B>Title of</B></TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Amount</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>maximum</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>maximum</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>Amount of</B></TD>
      <TD>&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
  
      <TD nowrap align="center"><B>securities to be</B></TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>to be</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>offering price</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>aggregate</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>registration</B></TD>
      <TD>&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>
  
      <TD nowrap align="center"><B>registered</B></TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>registered</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>per share</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>offering price</B></TD>
      <TD>&nbsp;</TD>
      <TD style="border-right: 1px solid #000000">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center" colspan="2"><B>fee</B></TD>
      <TD>&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom">
      <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
                      <TD style="border-top: 1px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock,
  $0.001 par value
  per share</DIV></TD>
      <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
      <TD style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD nowrap align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD align="right" style="border-top: 1px solid #000000">125,925</TD>
      <TD nowrap style="border-top: 1px solid #000000">(1)</TD>
      <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
      <TD style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD nowrap align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD align="center" style="border-top: 1px solid #000000">$58.31(2)</TD>
      <TD nowrap style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
      <TD style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD nowrap align="left" style="border-top: 1px solid #000000">$</TD>
      <TD align="right" style="border-top: 1px solid #000000">7,342,687 </TD>
      <TD nowrap style="border-top: 1px solid #000000">(2)</TD>
      <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
      <TD style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD nowrap align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD align="center" style="border-top: 1px solid #000000">$226(2)</TD>
      <TD nowrap style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD style="border-top: 1px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock,
  $0.001 par value
  per share</DIV></TD>
      <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
      <TD style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD nowrap align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD align="right" style="border-top: 1px solid #000000">254,914</TD>
      <TD nowrap style="border-top: 1px solid #000000">(3)</TD>
      <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
      <TD style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD nowrap align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD align="center" style="border-top: 1px solid #000000">$58.31(2)</TD>
      <TD nowrap style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
      <TD style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD nowrap align="left" style="border-top: 1px solid #000000">$</TD>
      <TD align="right" style="border-top: 1px solid #000000">14,864,036 </TD>
      <TD nowrap style="border-top: 1px solid #000000">(2)</TD>
      <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
      <TD style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD nowrap align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD align="center" style="border-top: 1px solid #000000">$457(2)</TD>
      <TD nowrap style="border-top: 1px solid #000000">&nbsp;</TD>
      <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
  </TR>
  <TR style="font-size: 1px" valign="bottom">
      <TD nowrap align="left" colspan="23" style="border-top: 3px double #000000">&nbsp;</TD>
  </TR>
  
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  <DIV style="margin-top: 6pt">
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="1%" nowrap align="left">(1)</TD>
      <TD width="1%">&nbsp;</TD>
      <TD>Represents shares of Inverness Medical Innovations, Inc. common stock issuable upon exercise
  of outstanding stock options granted pursuant to the HemoSense, Inc. Amended and Restated 1997
  Stock Plan.</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="1%" nowrap align="left">(2)</TD>
      <TD width="1%">&nbsp;</TD>
      <TD>Calculated pursuant to Rule 457(h) under the Securities Act of 1933, as amended, solely for
  the purposes of determining the amount of the registration fee.</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="1%" nowrap align="left">(3)</TD>
      <TD width="1%">&nbsp;</TD>
      <TD>Represents shares of Inverness Medical Innovations, Inc. common stock issuable upon exercise
  of outstanding stock options granted pursuant to the HemoSense, Inc. 2005 Equity Incentive
  Plan.</TD>
  </TR>
  
  </TABLE>
  </DIV>
  
  <DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
  <DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
  
  
  
  
  
  
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  <!-- TOC -->
  <A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>
  
  <P><CENTER>
  <TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
  <TR>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="3%"></TD>
  	<TD width="76%"></TD>
  </TR>
  <TR><TD colspan="9"><A HREF="#000">EXPLANATORY NOTE</A></TD></TR>
  <TR><TD colspan="9"><A HREF="#001">PART II<BR><BR> INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#002">Item&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporation of Documents by Reference</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#003">Item&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Description of Securities</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#004">Item&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest of Named Experts and Counsel</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#005">Item&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Indemnification of Directors and Officers</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#006">Item&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exemption from Registration Claimed.</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#007">Item&nbsp;8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.</A></TD></TR>
  <TR><TD></TD><TD colspan="8"><A HREF="#008">Item&nbsp;9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Undertakings</A></TD></TR>
  <TR><TD colspan="9"><A HREF="#009">SIGNATURES</A></TD></TR>
  <TR><TD colspan="9"><A HREF="#010">POWER OF ATTORNEY</A></TD></TR>
  <TR><TD colspan="9"><A HREF="#011">EXHIBIT INDEX</A></TD></TR>
  <TR><TD colspan="9"><A HREF="b67470meexv5w1.htm">EX-5.1 OPINION OF JAY MCNAMARA ESQ, SENIOR COUNSEL, CORPORATE AND FINANCE OF THE COMPANY</A></TD></TR>
  <TR><TD colspan="9"><A HREF="b67470meexv23w1.htm">EX-23.1 CONSENT OF BDO SEIDMAN, LLP.</A></TD></TR>
  <TR><TD colspan="9"><A HREF="b67470meexv23w2.htm">EX-23.2 CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></TD></TR>
  <TR><TD colspan="9"><A HREF="b67470meexv23w3.htm">EX-23.3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></TD></TR>
  <TR><TD colspan="9"><A HREF="b67470meexv23w4.htm">EX-23.4 CONSENT OF COLBY & COMPANY, PLC</A></TD></TR>
  </TABLE>
  </CENTER>
  <!-- /TOC -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  
  
  
  
  
  <!-- link1 "EXPLANATORY NOTE" -->
  <DIV align="left"><A NAME="000"></A></DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXPLANATORY NOTE</B>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This registration statement registers securities to be issued upon the exercise of options
  that Inverness Medical Innovations, Inc. (the &#147;Company&#148;) assumed upon the closing of the merger of
  HemoSense, Inc. with and into Spartan Merger Sub, Inc., a wholly owned subsidiary of the Company.
  </DIV>
  <!-- link1 "PART II<BR><BR> INFORMATION REQUIRED IN THE REGISTRATION STATEMENT" -->
  <DIV align="left"><A NAME="001"></A></DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PART II<BR><BR>
  INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>
  </DIV>
  
  <!-- link2 "Item&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporation of Documents by Reference" -->
  <DIV align="left"><A NAME="002"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;3.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Incorporation of Documents by Reference</B>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following documents filed with the Securities and Exchange Commission (SEC)&nbsp;are
  incorporated in this registration statement by reference:
  </DIV>
  
  <DIV style="margin-top: 6pt">
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s annual report on Form 10-K for the fiscal year ended December&nbsp;31,
  2006, filed with the SEC on March&nbsp;1, 2007, as amended on Form 10-K/A on March&nbsp;26, 2007
  (including the information incorporated by reference therein from the Company&#146;s
  definitive proxy statement filed with the SEC on April&nbsp;9, 2007);</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR>
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s quarterly report on Form 10-Q for the quarterly period ended March&nbsp;31,
  2007, filed with the SEC on May&nbsp;10, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR>
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s quarterly report on Form 10-Q for the quarterly period ended June&nbsp;30,
  2007, filed with the SEC on September&nbsp;9, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR>
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s quarterly report on Form 10-Q for the
  quarterly period ended September&nbsp;30, 2007, filed with the SEC on
  November&nbsp;8, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated January&nbsp;25, 2007, filed with the SEC
  on January&nbsp;26, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated March&nbsp;12, 2007, filed with the SEC on
  March&nbsp;16, 2007, as amended on April&nbsp;23, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated April&nbsp;5, 2007, filed with the SEC on
  April&nbsp;5, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated April&nbsp;25, 2007, filed with the SEC on
  April&nbsp;30, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated May&nbsp;9, 2007, filed with the SEC on
  May&nbsp;10, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated May&nbsp;11, 2007, filed with the SEC on
  May&nbsp;11, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated May&nbsp;9, 2007, filed with the SEC on
  May&nbsp;15, 2007;</TD>
  </TR>
  
  </TABLE>
  </DIV>
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  <DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated May&nbsp;14, 2007, filed with the SEC on
  May&nbsp;15, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated May&nbsp;17, 2007, filed with the SEC on
  May&nbsp;18, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated May&nbsp;17, 2007, filed with the SEC on
  May&nbsp;23, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated May&nbsp;29, 2007, filed with the SEC on
  May&nbsp;29, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated June&nbsp;4, 2007, filed with the SEC on
  June&nbsp;4, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated June&nbsp;12, 2007, filed with the SEC on
  June&nbsp;12, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s second current report on Form 8-K dated June&nbsp;12, 2007, filed with the
  SEC on June&nbsp;12, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated June&nbsp;26, 2007, filed with the SEC on
  July&nbsp;2, 2007, as amended on July&nbsp;20, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated July&nbsp;2, 2007, filed with the SEC on
  July&nbsp;3, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated July&nbsp;20, 2007, filed with the SEC on
  July&nbsp;20, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated July&nbsp;25, 2007, filed with the SEC on
  July&nbsp;26, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated August&nbsp;7, 2007, filed with the SEC on
  August&nbsp;7, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated August&nbsp;8, 2007, filed with the SEC on
  August&nbsp;8, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated August&nbsp;27, 2007, filed with the SEC
  on August&nbsp;28, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated September&nbsp;5, 2007, filed with the SEC
  on September&nbsp;5, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated September&nbsp;12, 2007, filed with the
  SEC on September&nbsp;17, 2007;</TD>
  </TR>
  
  </TABLE>
  </DIV>
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  
  <DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  
  
  <TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated September&nbsp;27, 2007, filed with the
  SEC on October&nbsp;1, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated October&nbsp;2, 2007, filed with the SEC
  on October&nbsp;2, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated October&nbsp;24, 2007, filed with the SEC
  on October&nbsp;26, 2007;</TD>
  </TR>
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>The Company&#146;s current report on Form 8-K dated
  November&nbsp;6, 2007, filed with the SEC
  on November&nbsp;8, 2007; and</TD>
  </TR>
  
  
  
  <TR>
      <TD style="font-size: 6pt">&nbsp;</TD>
  </TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
      <TD width="3%" style="background: transparent">&nbsp;</TD>
      <TD width="1%" nowrap align="left"><B>&#149;</B></TD>
      <TD width="1%">&nbsp;</TD>
      <TD>the description of the Company&#146;s common stock contained in its Registration
  Statement on Form 8-A filed with the SEC on November&nbsp;21, 2001, as amended, under
  Section&nbsp;12 of the Securities Exchange Act of 1934, as amended, and any amendments or
  reports filed for the purpose of updating such description.</TD>
  </TR>
  
  </TABLE>
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, all documents subsequently filed with the SEC by us pursuant to Sections&nbsp;13(a),
  13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, prior to the filing of a
  post-effective amendment hereto which indicates that all securities offered have been sold or which
  deregisters all securities then remaining unsold, are deemed to be incorporated by reference into,
  and to be a part of, this registration statement.
  </DIV>
  <!-- link2 "Item&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Description of Securities" -->
  <DIV align="left"><A NAME="003"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;4.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Description of Securities</B>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not Applicable.
  </DIV>
  <!-- link2 "Item&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest of Named Experts and Counsel" -->
  <DIV align="left"><A NAME="004"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;5.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Interest of Named Experts and Counsel</B>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of the securities the Company is offering is being passed upon by Jay McNamara,
  Esq., Senior Counsel, Corporate &#038; Finance, of the Company. Mr.&nbsp;McNamara owns an aggregate of
  approximately 2,663 shares of common stock of the Company, as well as options to purchase an
  additional 20,079 shares of common stock of the Company.
  </DIV>
  <!-- link2 "Item&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Indemnification of Directors and Officers" -->
  <DIV align="left"><A NAME="005"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Indemnification of Directors and Officers</B>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;145 of the Delaware General Corporation Law provides that a corporation may indemnify
  any person who was or is a party or is threatened to be made a party to any threatened, pending or
  completed action, suit or proceeding, whether civil, criminal, administrative or investigative,
  other than an action by or in the right of the corporation, by reason of the fact that the person
  is or was a director, officer, employee or agent of the corporation or is or was serving at the
  corporation&#146;s request as a director, officer, employee or agent of another corporation,
  partnership, joint venture, trust or other enterprise, against expenses, including attorneys&#146; fees,
  judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in
  connection with the action, suit or proceeding if the person acted in good faith and in a manner
  the person reasonably believed to be in or not opposed to the best interests of the corporation,
  and, with respect to any criminal action or proceeding, had no reasonable cause to believe the
  person&#146;s conduct was unlawful. The power to indemnify applies to actions brought by or in the right
  of the corporation as well, but only to the extent of expenses, including attorneys&#146; fees but
  excluding judgments, fines and amounts paid in settlement, actually and reasonably incurred by the
  person in connection with the defense or settlement of the action or suit. And with the further
  </DIV>
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">limitation that in these actions, no indemnification shall be made in the event of any
  adjudication of negligence or misconduct in the performance of the person&#146;s duties to the
  corporation, unless a court believes that in light of all the circumstances indemnification should
  apply.
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Article&nbsp;V of the Company&#146;s by-laws provides that the Company shall, to the extent legally
  permitted, indemnify each person who was or is a party or is threatened to be made a party to any
  threatened, pending or completed action, suit or proceeding by reason of the fact that such person
  is or was, or has agreed to become, a director or officer of the Company, or is or was serving, or
  has agreed to serve, at the request of the Company, as a director, officer, trustee, partner,
  employee or agent of, or in a similar capacity with, another corporation, partnership, joint
  venture, trust, employee benefit plan or other enterprise. The indemnification provided for in
  Article&nbsp;V is expressly not exclusive of any other rights to which those seeking indemnification may
  be entitled under any law, agreement or vote of stockholders or disinterested directors or
  otherwise, and shall inure to the benefit of the heirs, executors and administrators of such
  persons.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;145(g) of the Delaware General Corporation Law and Article&nbsp;V of the Company by-laws
  provide that the Company shall have the power to purchase and maintain insurance on behalf of its
  officers, directors, employees and agents, against any liability asserted against and incurred by
  such persons in any such capacity.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has obtained insurance covering its directors and officers against losses and
  insuring the Company against certain of its obligations to indemnify its directors and officers.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;102(b)(7) of the Delaware General Corporation Law provides that a corporation may
  eliminate or limit the personal liability of a director to the corporation or its stockholders for
  monetary damages for breach of fiduciary duty as a director, provided that such provisions shall
  not eliminate or limit the liability of a director (i)&nbsp;for any breach of the director&#146;s duty of
  loyalty to the corporation or its stockholders, (ii)&nbsp;for acts or omissions not in good faith or
  which involve intentional misconduct or a knowing violation of law, (iii)&nbsp;under section 174 of the
  Delaware General Corporation Law regarding the unlawful payment of dividends, or (iv)&nbsp;for any
  transaction from which the director derived an improper personal benefit. No such provision shall
  eliminate or limit the liability of a director for any act or omission occurring prior to the date
  when such provision becomes effective.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the Delaware General Corporation Law, Article&nbsp;VII of the Company&#146;s certificate of
  incorporation eliminates a director&#146;s personal liability for monetary damages to the Company and
  its stockholders for breach of fiduciary duty as a director, except in circumstances involving a
  breach of the director&#146;s duty of loyalty to the Company or its stockholders, acts or omissions not
  in good faith, intentional misconduct, knowing violations of the law, self-dealing or the unlawful
  payment of dividends or repurchase of stock.
  </DIV>
  <!-- link2 "Item&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exemption from Registration Claimed." -->
  <DIV align="left"><A NAME="006"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;7.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Exemption from Registration Claimed.</B>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not Applicable.
  </DIV>
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  <!-- link2 "Item&nbsp;8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits." -->
  <DIV align="left"><A NAME="007"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;8.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Exhibits.</B>
  </DIV>
  
  <DIV align="left">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="3%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="92%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 10pt" valign="bottom">
      <TD nowrap align="center"><B>Exhibit</B></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center">&nbsp;</TD>
  </TR>
  <TR style="font-size: 10pt" valign="bottom">
      <TD nowrap align="Center"><B><U>Number</U></B></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="left"><B><U>Description</U></B></TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Amended and Restated Certificate of Incorporation of the Company
  (incorporated by reference to Exhibit&nbsp;3.1 to the Company&#146;s Annual
  Report on Form&nbsp;10-K, as amended, for the year ended December&nbsp;31,
  2001).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Certificate of Designation, Preferences and Rights of Series&nbsp;A
  Convertible Preferred Stock of Inverness Medical Innovations, Inc.
  (incorporated by reference to Exhibit&nbsp;99.2 to the Company&#146;s
  Current Report on Form&nbsp;8-K dated December&nbsp;20, 2001).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.3
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Amended and Restated By-Laws of the Company (incorporated by
  reference to Exhibit&nbsp;3.3 to the Company&#146;s Annual Report on Form
  10-K, as amended, for the year ended December&nbsp;31, 2001).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.4
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Certificate of Amendment of Amended and Restated Certificate of
  Incorporation of the Company (incorporated by reference to Exhibit
  3.4 to the Company&#146;s Annual Report on Form&nbsp;10-K, as amended, for
  the year ended December&nbsp;31, 2006).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.5
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Certificate of Correction to the Amended and Restated Certificate
  of Incorporation of the Company (incorporated by reference to
  Exhibit&nbsp;3.5 to the Company&#146;s Annual Report on Form&nbsp;10-K, as
  amended, for the year ended December&nbsp;31, 2006).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.6
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">HemoSense, Inc. Amended and
  Restated 1997 Stock Plan (incorporated by reference to Exhibit 10.2
  to HemoSense, Inc.&#146;s Registration Statement on Form S-1, as amended (File No.
  333-123705), filed with the SEC on March&nbsp;31, 2005).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.7
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">HemoSense, Inc. 2005 Equity
  Incentive Plan (incorporated by reference to Exhibit 10.3
  to HemoSense, Inc.&#146;s Registration Statement on Form S-1, as amended (File No.
  333-123705), filed with the SEC on March&nbsp;31, 2005).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">*5.1
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Opinion of Jay McNamara, Esq, Senior Counsel, Corporate &#038; Finance,
  of the Company.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">*23.1
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Consent of BDO Seidman, LLP.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">*23.2
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Consent of PricewaterhouseCoopers LLP, Independent Registered
  Public Accounting Firm.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">*23.3
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Consent of Ernst &#038; Young LLP, Independent Registered Public
  Accounting Firm.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">*23.4
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Consent of Colby &#038; Company, PLC.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  <DIV align="left">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="3%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="92%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 10pt" valign="bottom">
      <TD nowrap align="center"><B>Exhibit</B></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center">&nbsp;</TD>
  </TR>
  <TR style="font-size: 10pt" valign="bottom">
      <TD nowrap align="center"><B><U>Number</U></B></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="left"><B><U>Description</U></B></TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  
  <TR>
      <TD>&nbsp;</TD>
  </TR>
  
  <TR valign="bottom">
  
  
  <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.5
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Consent of Jay McNamara, Esq., Senior Counsel, Corporate &#038;
  Finance, of the Company (included in Exhibit&nbsp;5.1).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Power of attorney (contained on the signature page to this
  registration statement).</TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  
  <DIV align="left">
  <DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
  </DIV>
  
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  <TR>
      <TD width="3%"></TD>
      <TD width="1%"></TD>
      <TD width="96"></TD>
  </TR>
  
  <TR valign="top">
      <TD nowrap align="left">*</TD>
      <TD>&nbsp;</TD>
      <TD>Filed herewith.</TD>
  </TR>
  
  </TABLE>
  
  
  <!-- link2 "Item&nbsp;9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Undertakings" -->
  <DIV align="left"><A NAME="008"></A></DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Undertakings</B>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned registrant hereby undertakes to:
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;(1)&nbsp;To file, during any period in which offers or sales are being made, a post-effective
  amendment to this registration statement:
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising after the effective date of the
  registration statement (or the most recent post-effective amendment thereof) which, individually or
  in the aggregate, represent a fundamental change in the information set forth in the registration
  statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered
  (if the total dollar value of securities offered would not exceed that which was registered) and
  any deviation from the low or high end of the estimated maximum offering range may be reflected in
  the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the
  changes in volume and price represent no more than 20% change in the maximum aggregate offering
  price set forth in the &#147;Calculation of Registration Fee&#148; table in the effective registration
  statement; and
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the plan of distribution not
  previously disclosed in the registration statement or any material change to such information in
  the registration statement; <I>provided, however</I>, that Paragraphs (a)(1)(i) and (a)(1)(ii) do not
  apply if the information required to be included in a post-effective amendment by those paragraphs
  is contained in reports filed with or furnished to the Commission by the registrant pursuant to
  section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by
  reference in the registration statement.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;That, for the purpose of determining any liability under the Securities Act of 1933, each
  such post-effective amendment shall be deemed to be a new registration statement relating to the
  securities offered therein, and the offering of such securities at that time shall be deemed to be
  the initial <I>bona fide </I>offering thereof.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;To remove from registration by means of a post-effective amendment any of the securities
  being registered which remain unsold at the termination of the offering.
  </DIV>
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The undersigned registrant hereby undertakes that, for purposes of determining any
  liability under the Securities Act of 1933, each filing of the registrant&#146;s annual report pursuant
  to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
  each filing of an employee benefit plan&#146;s annual report pursuant to Section 15(d) of the Securities
  Exchange Act of 1934) that is incorporated by reference in the registration statement shall be
  deemed to be a new registration statement relating to the securities offered therein, and the
  offering of such securities at that time shall be deemed to be the initial <I>bona fide </I>offering
  thereof.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Insofar as indemnification for liabilities arising under the Securities Act of 1933 may
  be permitted to directors, officers and controlling persons of the registrant pursuant to the
  foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
  Securities and Exchange Commission such indemnification is against public policy as expressed in
  the Act and is, therefore, unenforceable. In the event that a claim for indemnification against
  such liabilities (other than the payment by the registrant of expenses incurred or paid by a
  director, officer or controlling person of the registrant in the successful defense of any action,
  suit or proceeding) is asserted by such director, officer or controlling person in connection with
  the securities being registered, the registrant will, unless in the opinion of its counsel the
  matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
  question whether such indemnification by it is against public policy as expressed in the Act and
  will be governed by the final adjudication of such issue.
  </DIV>
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  <!-- link1 "SIGNATURES" -->
  <DIV align="left"><A NAME="009"></A></DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
  </DIV>
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
  has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
  has duly caused this registration statement to be signed on its behalf by the undersigned,
  thereunto duly authorized, in the City of Waltham, The Commonwealth
  of Massachusetts, on November&nbsp;8, 2007.
  </DIV>
  
  <TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
  <TR>
      <TD width="48%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="1%">&nbsp;</TD>
      <TD width="35%">&nbsp;</TD>
      <TD width="15%">&nbsp;</TD>
  </TR>
  <TR>
      <TD valign="top" align="left">&nbsp;</TD>
      <TD colspan="3" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Inverness Medical Innovations, Inc.</B></FONT><BR>
  &nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR><TR>
      <TD align="left">&nbsp;</TD>
      <TD valign="top">By:&nbsp;&nbsp;</TD>
  
  <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ RON ZWANZIGER
  &nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR><TR>
      <TD align="left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD colspan="2" align="left">Ron Zwanziger&nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR><TR>
      <TD align="left">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD colspan="2" align="left">Chairman, Chief Executive Officer and President&nbsp;</TD>
      <TD>&nbsp;</TD>
  </TR>
  <TR>
      <TD colspan="5">&nbsp;</TD>
  </TR>
  </TABLE>
  <!-- link1 "POWER OF ATTORNEY" -->
  <DIV align="left"><A NAME="010"></A></DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>POWER OF ATTORNEY</B>
  </DIV>
  
  
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KNOW ALL MEN BY THESE PRESENTS that each individual whose signature appears below constitutes
  and appoints Ron Zwanziger and David Teitel, and each of them, his or her true and lawful
  attorneys-in-fact and agents with full power of substitution, for him or her and in his or her
  name, place and stead, in any and all capacities, to sign any and all pre- or post-effective
  amendments to this registration statement, and any subsequent registration statement for the same
  offering which may be filed under Rule 462(b) under the Securities Act (a &#147;Rule&nbsp;462(b) registration
  statement&#148;) and any and all pre- or post-effective amendments thereto, and to file the same, with
  all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange
  Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and
  authority to do and perform each and every act and thing which they, or any of them, may deem
  necessary or advisable to be done in connection with this registration statement or any Rule 462(b)
  registration statement, as fully to all intents and purposes as he or she might or could do in
  person, hereby ratifying and confirming all that said attorneys-in-fact and agent or any of them,
  or substitutes for any or all of them, may lawfully do or cause to be done by virtue hereof.
  </DIV>
  
  <DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this registration statement has
  been signed by the following persons in the capacities and on the dates indicated.
  </DIV>
  
  <DIV align="left">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="30%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="34%">&nbsp;</TD>
      <TD width="3%">&nbsp;</TD>
      <TD width="30%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 10pt" valign="bottom">
      <TD nowrap align="center"><U><B>Signature</B></U></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B><U>Title</U></B></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B><u>Date</U></B></TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="center" nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="center" valign="top">/s/ RON ZWANZIGER<BR>
  <DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
  Ron Zwanziger</TD>
      <TD>&nbsp;</TD>
      <TD align="left">
  Chief Executive Officer, President and Director<BR>
  (Principal Executive Officer)
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">November&nbsp;8, 2007
  </TD>
  </TR>
  
  <TR valign="bottom" style="padding-top: 1em"><!-- Blank Space -->
      <TD align="right">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="center" nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="center" valign="top">/s/ DAVID TEITEL&nbsp;<BR>
  <DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
  David Teitel</TD>
      <TD>&nbsp;</TD>
      <TD align="left">
  Chief Financial Officer<br>
  (Principal Financial Officer and Principal
  Accounting Officer)
  </TD>
      <TD>&nbsp;</TD>
  <TD align="center" valign="top">November&nbsp;8, 2007</TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  <DIV align="left">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="30%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="30%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="30%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 10pt" valign="bottom">
      <TD nowrap align="center"><U><B>Signature</B></U></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B><U>Title</U></B></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center"><B><u>Date</U></B></TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom" style="padding-top: 1em"><!-- Blank Space -->
      <TD align="right">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="center" nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="center" valign="top">/s/ CAROL R. GOLDBERG&nbsp;<BR>
  <DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
  Carol R. Goldberg</TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">November&nbsp;8, 2007
  </TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em"><!-- Blank Space -->
      <TD align="right">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="center" nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="center" valign="top">/s/ ROBERT KHEDERIAN&nbsp;<BR>
  <DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
  Robert Khederian</TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">November&nbsp;8, 2007
  </TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em"><!-- Blank Space -->
      <TD align="right">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="center" nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="center" valign="top">/s/ JOHN F. LEVY&nbsp;<BR>
  <DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
  John F. Levy</TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">November&nbsp;8, 2007
  
  </TR>
  <TR valign="bottom" style="padding-top: 1em"><!-- Blank Space -->
      <TD align="right">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="center" nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="center" valign="top">/s/ JERRY MCALEER, PH.D.&nbsp;<BR>
  <DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
  Jerry McAleer, Ph.D.</TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">November&nbsp;8, 2007
  
  </TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em"><!-- Blank Space -->
      <TD align="right">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="center" nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="center" valign="top">&nbsp;<BR>
  <DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
  John A. Quelch</TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">November&nbsp;8, 2007
  
  </TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em"><!-- Blank Space -->
      <TD align="right">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="center" nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="center" valign="top">/s/ DAVID SCOTT, PH.D.&nbsp;<BR>
  <DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
  David Scott, Ph.D.</TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">November&nbsp;8, 2007
  </TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em"><!-- Blank Space -->
      <TD align="right">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="center" nowrap valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom" style="padding-top: 1em">
      <TD align="center" valign="top">&nbsp;<BR>
  <DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
  Peter Townsend</TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">
  Director
  </TD>
      <TD>&nbsp;</TD>
      <TD align="center" valign="top">November&nbsp;8, 2007
  </TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  <!-- link1 "EXHIBIT INDEX" -->
  <DIV align="left"><A NAME="011"></A></DIV>
  
  <DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT INDEX</B>
  </DIV>
  
  <DIV align="left">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="3%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="92%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 10pt" valign="bottom">
      <TD nowrap align="center"><B>Exhibit</B></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center">&nbsp;</TD>
  </TR>
  <TR style="font-size: 10pt" valign="bottom">
      <TD nowrap align="center"><B><U>Number</U></B></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="left"><B><U>Description</U></B></TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Amended and Restated Certificate of Incorporation of the Company
  (incorporated by reference to Exhibit&nbsp;3.1 to the Company&#146;s Annual
  Report on Form&nbsp;10-K, as amended, for the year ended December&nbsp;31,
  2001).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Certificate of Designation, Preferences and Rights of Series&nbsp;A
  Convertible Preferred Stock of Inverness Medical Innovations, Inc.
  (incorporated by reference to Exhibit&nbsp;99.2 to the Company&#146;s
  Current Report on Form&nbsp;8-K dated December&nbsp;20, 2001).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.3
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Amended and Restated By-Laws of the Company (incorporated by
  reference to Exhibit&nbsp;3.3 to the Company&#146;s Annual Report on Form
  10-K, as amended, for the year ended December&nbsp;31, 2001).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.4
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Certificate of Amendment of Amended and Restated Certificate of
  Incorporation of the Company (incorporated by reference to Exhibit
  3.4 to the Company&#146;s Annual Report on Form&nbsp;10-K, as amended, for
  the year ended December&nbsp;31, 2006).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.5
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Certificate of Correction to the Amended and Restated Certificate
  of Incorporation of the Company (incorporated by reference to
  Exhibit&nbsp;3.5 to the Company&#146;s Annual Report on Form&nbsp;10-K, as
  amended, for the year ended December&nbsp;31, 2006).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.6
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">HemoSense, Inc. Amended and
  Restated 1997 Stock Plan (incorporated by reference to Exhibit 10.2
  to HemoSense, Inc.&#146;s Registration Statement on Form S-1, as
  amended (File No. 333-123705), filed with the SEC on March&nbsp;31,
  2005).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.7
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">HemoSense, Inc. 2005 Equity
  Incentive Plan (incorporated by reference to Exhibit 10.3 to
  HemoSense, Inc.&#146;s Registration Statement on Form S-1, as amended
  (File No. 333-123705), filed with the SEC on March&nbsp;31, 2005.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">*5.1
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Opinion of Jay McNamara, Esq, Senior Counsel, Corporate &#038; Finance,
  of the Company.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">*23.1
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Consent of BDO Seidman, LLP.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">*23.2
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Consent of PricewaterhouseCoopers LLP, Independent Registered
  Public Accounting Firm.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">*23.3
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Consent of Ernst &#038; Young LLP, Independent Registered Public
  Accounting Firm.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">*23.4
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Consent of Colby &#038; Company, PLC.</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  <!-- PAGEBREAK -->
  <P><HR noshade><P>
  <H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
  
  <DIV style="font-family: 'Times New Roman',Times,serif">
  
  <DIV align="left">
  <TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
  <!-- Begin Table Head -->
  <TR valign="bottom">
      <TD width="3%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="92%">&nbsp;</TD>
  </TR>
  <TR style="font-size: 10pt" valign="bottom">
      <TD nowrap align="center"><B>Exhibit</B></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="center">&nbsp;</TD>
  </TR>
  <TR style="font-size: 10pt" valign="bottom">
      <TD nowrap align="center"><B><U>Number</U></B></TD>
      <TD>&nbsp;</TD>
      <TD nowrap align="left"><B><U>Description</U></B></TD>
  </TR>
  
  <!-- End Table Head -->
  <!-- Begin Table Body -->
  <TR>
      <TD>&nbsp;</TD>
  </TR>
  
  <TR valign="bottom">
  
  <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.5
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Consent of Jay McNamara, Esq., Senior Counsel, Corporate &#038;
  Finance, of the Company (included in Exhibit&nbsp;5.1).</TD>
  </TR>
  <TR valign="bottom"><!-- Blank Space -->
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
  </TR>
  <TR valign="bottom">
      <TD align="right" valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1
  </DIV></TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">Power of attorney (contained on the signature page to this
  registration statement).</TD>
  </TR>
  <!-- End Table Body -->
  </TABLE>
  </DIV>
  
  
  
  <DIV align="left">
  <DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
  </DIV>
  
  <TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
  <TR>
      <TD width="3%"></TD>
      <TD width="1%"></TD>
      <TD width="96"></TD>
  </TR>
  
  <TR valign="top">
      <TD nowrap align="left">*</TD>
      <TD>&nbsp;</TD>
      <TD>Filed herewith.</TD>
  </TR>
  
  </TABLE>
  
  
  
  
  <P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
  </DIV>
  
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "S-8", "sequence": "1", "filename": "b67470mesv8.htm", "description": "INVERNESS MEDICAL INNOVATIONS, INC.", "secsgml_size_bytes": 78678}]
metadata_filer: {"company-data": {"conformed-name": "INVERNESS MEDICAL INNOVATIONS INC", "cik": "0001145460", "assigned-sic": "2835", "irs-number": "043565120", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-147242", "film-number": "071226890"}, "business-address": {"street1": "51 SAWYER ROAD", "street2": "SUITE 200", "city": "WALTHAM", "state": "MA", "zip": "02453", "phone": "7816473900"}, "mail-address": {"street1": "51 SAWYER ROAD", "street2": "SUITE 200", "city": "WALTHAM", "state": "MA", "zip": "02453"}}
text: sv8
  Table of Contents
  As filed with the Securities and Exchange
  Commission on November 8, 2007
  Registration No. 333-
  UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM S-8
  REGISTRATION STATEMENT
  UNDER
  THE SECURITIES ACT OF 1933
  Inverness Medical Innovations, Inc.
  (Exact name of registrant as specified in its charter)
  Delaware
  (State or other jurisdiction of
  incorporation or organization)
  51 Sawyer Road, Suite 200
  Waltham, Massachusetts 02453
  (781) 647-3900
  (Address of Registrant's Principal
  Executive Offices)
  04-3565120
  (I.R.S. Employer
  Identification No.)
  HemoSense, Inc. Amended and Restated 1997 Stock Plan
  HemoSense, Inc. 2005 Equity Incentive Plan
  (Full titles of the plans)
  Ron Zwanziger
  Chairman, Chief Executive Officer and President
  Inverness Medical Innovations, Inc.
  51 Sawyer Road, Suite 200
  Waltham, Massachusetts 02453
  (781) 647-3900
  (Name, address, including zip code, and telephone number,
  including area code, of agent for service)
  With a copy to:
  Jay McNamara, Esq.
  Senior Counsel, Corporate & Finance
  Inverness Medical Innovations, Inc.
  51 Sawyer Road, Suite 200
  Waltham, Massachusetts 02453
  (781) 647-3900
  CALCULATION OF REGISTRATION FEE
  Proposed
  Proposed
  Title of
  Amount
  maximum
  maximum
  Amount of
  securities to be
  to be
  offering price
  aggregate
  registration
  registered
  registered
  per share
  offering price
  fee
  Common Stock,
  $0.001 par value
  per share
  125,925
  (1)
  $58.31(2)
  $
  7,342,687
  (2)
  $226(2)
  Common Stock,
  $0.001 par value
  per share
  254,914
  (3)
  $58.31(2)
  $
  14,864,036
  (2)
  $457(2)
  (1)
  Represents shares of Inverness Medical Innovations, Inc. common stock issuable upon exercise
  of outstanding stock options granted pursuant to the HemoSense, Inc. Amended and Restated 1997
  Stock Plan.
  (2)
  Calculated pursuant to Rule 457(h) under the Securities Act of 1933, as amended, solely for
  the purposes of determining the amount of the registration fee.
  (3)
  Represents shares of Inverness Medical Innovations, Inc. common stock issuable upon exercise
  of outstanding stock options granted pursuant to the HemoSense, Inc. 2005 Equity Incentive
  Plan.
  TABLE OF CONTENTS
  EXPLANATORY NOTE
  PART II
  INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  Item 3.     Incorporation of Documents by Reference
  Item 4.     Description of Securities
  Item 5.     Interest of Named Experts and Counsel
  Item 6.      Indemnification of Directors and Officers
  Item 7.     Exemption from Registration Claimed.
  Item 8.     Exhibits.
  Item 9.     Undertakings
  SIGNATURES
  POWER OF ATTORNEY
  EXHIBIT INDEX
  EX-5.1 OPINION OF JAY MCNAMARA ESQ, SENIOR COUNSEL, CORPORATE AND FINANCE OF THE COMPANY
  EX-23.1 CONSENT OF BDO SEIDMAN, LLP.
  EX-23.2 CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EX-23.3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EX-23.4 CONSENT OF COLBY & COMPANY, PLC
  Table of Contents
  EXPLANATORY NOTE
  This registration statement registers securities to be issued upon the exercise of options
  that Inverness Medical Innovations, Inc. (the "Company") assumed upon the closing of the merger of
  HemoSense, Inc. with and into Spartan Merger Sub, Inc., a wholly owned subsidiary of the Company.
  PART II
  INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
  Item 3.
  Incorporation of Documents by Reference
  The following documents filed with the Securities and Exchange Commission (SEC) are
  incorporated in this registration statement by reference:
  •
  The Company's annual report on Form 10-K for the fiscal year ended December 31,
  2006, filed with the SEC on March 1, 2007, as amended on Form 10-K/A on March 26, 2007
  (including the information incorporated by reference therein from the Company's
  definitive proxy statement filed with the SEC on April 9, 2007);
  •
  The Company's quarterly report on Form 10-Q for the quarterly period ended March 31,
  2007, filed with the SEC on May 10, 2007;
  •
  The Company's quarterly report on Form 10-Q for the quarterly period ended June 30,
  2007, filed with the SEC on September 9, 2007;
  •
  The Company's quarterly report on Form 10-Q for the
  quarterly period ended September 30, 2007, filed with the SEC on
  November 8, 2007;
  •
  The Company's current report on Form 8-K dated January 25, 2007, filed with the SEC
  on January 26, 2007;
  •
  The Company's current report on Form 8-K dated March 12, 2007, filed with the SEC on
  March 16, 2007, as amended on April 23, 2007;
  •
  The Company's current report on Form 8-K dated April 5, 2007, filed with the SEC on
  April 5, 2007;
  •
  The Company's current report on Form 8-K dated April 25, 2007, filed with the SEC on
  April 30, 2007;
  •
  The Company's current report on Form 8-K dated May 9, 2007, filed with the SEC on
  May 10, 2007;
  •
  The Company's current report on Form 8-K dated May 11, 2007, filed with the SEC on
  May 11, 2007;
  •
  The Company's current report on Form 8-K dated May 9, 2007, filed with the SEC on
  May 15, 2007;
  Table of Contents
  •
  The Company's current report on Form 8-K dated May 14, 2007, filed with the SEC on
  May 15, 2007;
  •
  The Company's current report on Form 8-K dated May 17, 2007, filed with the SEC on
  May 18, 2007;
  •
  The Company's current report on Form 8-K dated May 17, 2007, filed with the SEC on
  May 23, 2007;
  •
  The Company's current report on Form 8-K dated May 29, 2007, filed with the SEC on
  May 29, 2007;
  •
  The Company's current report on Form 8-K dated June 4, 2007, filed with the SEC on
  June 4, 2007;
  •
  The Company's current report on Form 8-K dated June 12, 2007, filed with the SEC on
  June 12, 2007;
  •
  The Company's second current report on Form 8-K dated June 12, 2007, filed with the
  SEC on June 12, 2007;
  •
  The Company's current report on Form 8-K dated June 26, 2007, filed with the SEC on
  July 2, 2007, as amended on July 20, 2007;
  •
  The Company's current report on Form 8-K dated July 2, 2007, filed with the SEC on
  July 3, 2007;
  •
  The Company's current report on Form 8-K dated July 20, 2007, filed with the SEC on
  July 20, 2007;
  •
  The Company's current report on Form 8-K dated July 25, 2007, filed with the SEC on
  July 26, 2007;
  •
  The Company's current report on Form 8-K dated August 7, 2007, filed with the SEC on
  August 7, 2007;
  •
  The Company's current report on Form 8-K dated August 8, 2007, filed with the SEC on
  August 8, 2007;
  •
  The Company's current report on Form 8-K dated August 27, 2007, filed with the SEC
  on August 28, 2007;
  •
  The Company's current report on Form 8-K dated September 5, 2007, filed with the SEC
  on September 5, 2007;
  •
  The Company's current report on Form 8-K dated September 12, 2007, filed with the
  SEC on September 17, 2007;
  Table of Contents
  •
  The Company's current report on Form 8-K dated September 27, 2007, filed with the
  SEC on October 1, 2007;
  •
  The Company's current report on Form 8-K dated October 2, 2007, filed with the SEC
  on October 2, 2007;
  •
  The Company's current report on Form 8-K dated October 24, 2007, filed with the SEC
  on October 26, 2007;
  •
  The Company's current report on Form 8-K dated
  November 6, 2007, filed with the SEC
  on November 8, 2007; and
  •
  the description of the Company's common stock contained in its Registration
  Statement on Form 8-A filed with the SEC on November 21, 2001, as amended, under
  Section 12 of the Securities Exchange Act of 1934, as amended, and any amendments or
  reports filed for the purpose of updating such description.
  In addition, all documents subsequently filed with the SEC by us pursuant to Sections 13(a),
  13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, prior to the filing of a
  post-effective amendment hereto which indicates that all securities offered have been sold or which
  deregisters all securities then remaining unsold, are deemed to be incorporated by reference into,
  and to be a part of, this registration statement.
  Item 4.
  Description of Securities
  Not Applicable.
  Item 5.
  Interest of Named Experts and Counsel
  The validity of the securities the Company is offering is being passed upon by Jay McNamara,
  Esq., Senior Counsel, Corporate & Finance, of the Company. Mr. McNamara owns an aggregate of
  approximately 2,663 shares of common stock of the Company, as well as options to purchase an
  additional 20,079 shares of common stock of the Company.
  Item 6.      Indemnification of Directors and Officers
  Section 145 of the Delaware General Corporation Law provides that a corporation may indemnify
  any person who was or is a party or is threatened to be made a party to any threatened, pending or
  completed action, suit or proceeding, whether civil, criminal, administrative or investigative,
  other than an action by or in the right of the corporation, by reason of the fact that the person
  is or was a director, officer, employee or agent of the corporation or is or was serving at the
  corporation's request as a director, officer, employee or agent of another corporation,
  partnership, joint venture, trust or other enterprise, against expenses, including attorneys' fees,
  judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in
  connection with the action, suit or proceeding if the person acted in good faith and in a manner
  the person reasonably believed to be in or not opposed to the best interests of the corporation,
  and, with respect to any criminal action or proceeding, had no reasonable cause to believe the
  person's conduct was unlawful. The power to indemnify applies to actions brought by or in the right
  of the corporation as well, but only to the extent of expenses, including attorneys' fees but
  excluding judgments, fines and amounts paid in settlement, actually and reasonably incurred by the
  person in connection with the defense or settlement of the action or suit. And with the further
  Table of Contents
  limitation that in these actions, no indemnification shall be made in the event of any
  adjudication of negligence or misconduct in the performance of the person's duties to the
  corporation, unless a court believes that in light of all the circumstances indemnification should
  apply.
  Article V of the Company's by-laws provides that the Company shall, to the extent legally
  permitted, indemnify each person who was or is a party or is threatened to be made a party to any
  threatened, pending or completed action, suit or proceeding by reason of the fact that such person
  is or was, or has agreed to become, a director or officer of the Company, or is or was serving, or
  has agreed to serve, at the request of the Company, as a director, officer, trustee, partner,
  employee or agent of, or in a similar capacity with, another corporation, partnership, joint
  venture, trust, employee benefit plan or other enterprise. The indemnification provided for in
  Article V is expressly not exclusive of any other rights to which those seeking indemnification may
  be entitled under any law, agreement or vote of stockholders or disinterested directors or
  otherwise, and shall inure to the benefit of the heirs, executors and administrators of such
  persons.
  Section 145(g) of the Delaware General Corporation Law and Article V of the Company by-laws
  provide that the Company shall have the power to purchase and maintain insurance on behalf of its
  officers, directors, employees and agents, against any liability asserted against and incurred by
  such persons in any such capacity.
  The Company has obtained insurance covering its directors and officers against losses and
  insuring the Company against certain of its obligations to indemnify its directors and officers.
  Section 102(b)(7) of the Delaware General Corporation Law provides that a corporation may
  eliminate or limit the personal liability of a director to the corporation or its stockholders for
  monetary damages for breach of fiduciary duty as a director, provided that such provisions shall
  not eliminate or limit the liability of a director (i) for any breach of the director's duty of
  loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or
  which involve intentional misconduct or a knowing violation of law, (iii) under section 174 of the
  Delaware General Corporation Law regarding the unlawful payment of dividends, or (iv) for any
  transaction from which the director derived an improper personal benefit. No such provision shall
  eliminate or limit the liability of a director for any act or omission occurring prior to the date
  when such provision becomes effective.
  Pursuant to the Delaware General Corporation Law, Article VII of the Company's certificate of
  incorporation eliminates a director's personal liability for monetary damages to the Company and
  its stockholders for breach of fiduciary duty as a director, except in circumstances involving a
  breach of the director's duty of loyalty to the Company or its stockholders, acts or omissions not
  in good faith, intentional misconduct, knowing violations of the law, self-dealing or the unlawful
  payment of dividends or repurchase of stock.
  Item 7.
  Exemption from Registration Claimed.
  Not Applicable.
  Table of Contents
  Item 8.
  Exhibits.
  Exhibit
  Number
  Description
  4.1
  Amended and Restated Certificate of Incorporation of the Company
  (incorporated by reference to Exhibit 3.1 to the Company's Annual
  Report on Form 10-K, as amended, for the year ended December 31,
  2001).
  4.2
  Certificate of Designation, Preferences and Rights of Series A
  Convertible Preferred Stock of Inverness Medical Innovations, Inc.
  (incorporated by reference to Exhibit 99.2 to the Company's
  Current Report on Form 8-K dated December 20, 2001).
  4.3
  Amended and Restated By-Laws of the Company (incorporated by
  reference to Exhibit 3.3 to the Company's Annual Report on Form
  10-K, as amended, for the year ended December 31, 2001).
  4.4
  Certificate of Amendment of Amended and Restated Certificate of
  Incorporation of the Company (incorporated by reference to Exhibit
  3.4 to the Company's Annual Report on Form 10-K, as amended, for
  the year ended December 31, 2006).
  4.5
  Certificate of Correction to the Amended and Restated Certificate
  of Incorporation of the Company (incorporated by reference to
  Exhibit 3.5 to the Company's Annual Report on Form 10-K, as
  amended, for the year ended December 31, 2006).
  4.6
  HemoSense, Inc. Amended and
  Restated 1997 Stock Plan (incorporated by reference to Exhibit 10.2
  to HemoSense, Inc.'s Registration Statement on Form S-1, as amended (File No.
  333-123705), filed with the SEC on March 31, 2005).
  4.7
  HemoSense, Inc. 2005 Equity
  Incentive Plan (incorporated by reference to Exhibit 10.3
  to HemoSense, Inc.'s Registration Statement on Form S-1, as amended (File No.
  333-123705), filed with the SEC on March 31, 2005).
  *5.1
  Opinion of Jay McNamara, Esq, Senior Counsel, Corporate & Finance,
  of the Company.
  *23.1
  Consent of BDO Seidman, LLP.
  *23.2
  Consent of PricewaterhouseCoopers LLP, Independent Registered
  Public Accounting Firm.
  *23.3
  Consent of Ernst & Young LLP, Independent Registered Public
  Accounting Firm.
  *23.4
  Consent of Colby & Company, PLC.
  Table of Contents
  Exhibit
  Number
  Description
  23.5
  Consent of Jay McNamara, Esq., Senior Counsel, Corporate &
  Finance, of the Company (included in Exhibit 5.1).
  24.1
  Power of attorney (contained on the signature page to this
  registration statement).
  *
  Filed herewith.
  Item 9.
  Undertakings
  The undersigned registrant hereby undertakes to:
  (a) (1) To file, during any period in which offers or sales are being made, a post-effective
  amendment to this registration statement:
  (i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;
  (ii) To reflect in the prospectus any facts or events arising after the effective date of the
  registration statement (or the most recent post-effective amendment thereof) which, individually or
  in the aggregate, represent a fundamental change in the information set forth in the registration
  statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered
  (if the total dollar value of securities offered would not exceed that which was registered) and
  any deviation from the low or high end of the estimated maximum offering range may be reflected in
  the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the
  changes in volume and price represent no more than 20% change in the maximum aggregate offering
  price set forth in the "Calculation of Registration Fee" table in the effective registration
  statement; and
  (iii) To include any material information with respect to the plan of distribution not
  previously disclosed in the registration statement or any material change to such information in
  the registration statement;
  provided, however
  , that Paragraphs (a)(1)(i) and (a)(1)(ii) do not
  apply if the information required to be included in a post-effective amendment by those paragraphs
  is contained in reports filed with or furnished to the Commission by the registrant pursuant to
  section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by
  reference in the registration statement.
  (2) That, for the purpose of determining any liability under the Securities Act of 1933, each
  such post-effective amendment shall be deemed to be a new registration statement relating to the
  securities offered therein, and the offering of such securities at that time shall be deemed to be
  the initial
  bona fide
  offering thereof.
  (3) To remove from registration by means of a post-effective amendment any of the securities
  being registered which remain unsold at the termination of the offering.
  Table of Contents
  (b) The undersigned registrant hereby undertakes that, for purposes of determining any
  liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant
  to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
  each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities
  Exchange Act of 1934) that is incorporated by reference in the registration statement shall be
  deemed to be a new registration statement relating to the securities offered therein, and the
  offering of such securities at that time shall be deemed to be the initial
  bona fide
  offering
  thereof.
  (c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may
  be permitted to directors, officers and controlling persons of the registrant pursuant to the
  foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
  Securities and Exchange Commission such indemnification is against public policy as expressed in
  the Act and is, therefore, unenforceable. In the event that a claim for indemnification against
  such liabilities (other than the payment by the registrant of expenses incurred or paid by a
  director, officer or controlling person of the registrant in the successful defense of any action,
  suit or proceeding) is asserted by such director, officer or controlling person in connection with
  the securities being registered, the registrant will, unless in the opinion of its counsel the
  matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
  question whether such indemnification by it is against public policy as expressed in the Act and
  will be governed by the final adjudication of such issue.
  Table of Contents
  SIGNATURES
  Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
  has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
  has duly caused this registration statement to be signed on its behalf by the undersigned,
  thereunto duly authorized, in the City of Waltham, The Commonwealth
  of Massachusetts, on November 8, 2007.
  Inverness Medical Innovations, Inc.
  By:
  /s/ RON ZWANZIGER
  Ron Zwanziger
  Chairman, Chief Executive Officer and President
  POWER OF ATTORNEY
  KNOW ALL MEN BY THESE PRESENTS that each individual whose signature appears below constitutes
  and appoints Ron Zwanziger and David Teitel, and each of them, his or her true and lawful
  attorneys-in-fact and agents with full power of substitution, for him or her and in his or her
  name, place and stead, in any and all capacities, to sign any and all pre- or post-effective
  amendments to this registration statement, and any subsequent registration statement for the same
  offering which may be filed under Rule 462(b) under the Securities Act (a "Rule 462(b) registration
  statement") and any and all pre- or post-effective amendments thereto, and to file the same, with
  all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange
  Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and
  authority to do and perform each and every act and thing which they, or any of them, may deem
  necessary or advisable to be done in connection with this registration statement or any Rule 462(b)
  registration statement, as fully to all intents and purposes as he or she might or could do in
  person, hereby ratifying and confirming all that said attorneys-in-fact and agent or any of them,
  or substitutes for any or all of them, may lawfully do or cause to be done by virtue hereof.
  Pursuant to the requirements of the Securities Act of 1933, this registration statement has
  been signed by the following persons in the capacities and on the dates indicated.
  Signature
  Title
  Date
  /s/ RON ZWANZIGER
  Ron Zwanziger
  Chief Executive Officer, President and Director
  (Principal Executive Officer)
  November 8, 2007
  /s/ DAVID TEITEL
  David Teitel
  Chief Financial Officer
  (Principal Financial Officer and Principal
  Accounting Officer)
  November 8, 2007
  Table of Contents
  Signature
  Title
  Date
  /s/ CAROL R. GOLDBERG
  Carol R. Goldberg
  Director
  November 8, 2007
  /s/ ROBERT KHEDERIAN
  Robert Khederian
  Director
  November 8, 2007
  /s/ JOHN F. LEVY
  John F. Levy
  Director
  November 8, 2007
  /s/ JERRY MCALEER, PH.D.
  Jerry McAleer, Ph.D.
  Director
  November 8, 2007
  John A. Quelch
  Director
  November 8, 2007
  /s/ DAVID SCOTT, PH.D.
  David Scott, Ph.D.
  Director
  November 8, 2007
  Peter Townsend
  Director
  November 8, 2007
  Table of Contents
  EXHIBIT INDEX
  Exhibit
  Number
  Description
  4.1
  Amended and Restated Certificate of Incorporation of the Company
  (incorporated by reference to Exhibit 3.1 to the Company's Annual
  Report on Form 10-K, as amended, for the year ended December 31,
  2001).
  4.2
  Certificate of Designation, Preferences and Rights of Series A
  Convertible Preferred Stock of Inverness Medical Innovations, Inc.
  (incorporated by reference to Exhibit 99.2 to the Company's
  Current Report on Form 8-K dated December 20, 2001).
  4.3
  Amended and Restated By-Laws of the Company (incorporated by
  reference to Exhibit 3.3 to the Company's Annual Report on Form
  10-K, as amended, for the year ended December 31, 2001).
  4.4
  Certificate of Amendment of Amended and Restated Certificate of
  Incorporation of the Company (incorporated by reference to Exhibit
  3.4 to the Company's Annual Report on Form 10-K, as amended, for
  the year ended December 31, 2006).
  4.5
  Certificate of Correction to the Amended and Restated Certificate
  of Incorporation of the Company (incorporated by reference to
  Exhibit 3.5 to the Company's Annual Report on Form 10-K, as
  amended, for the year ended December 31, 2006).
  4.6
  HemoSense, Inc. Amended and
  Restated 1997 Stock Plan (incorporated by reference to Exhibit 10.2
  to HemoSense, Inc.'s Registration Statement on Form S-1, as
  amended (File No. 333-123705), filed with the SEC on March 31,
  2005).
  4.7
  HemoSense, Inc. 2005 Equity
  Incentive Plan (incorporated by reference to Exhibit 10.3 to
  HemoSense, Inc.'s Registration Statement on Form S-1, as amended
  (File No. 333-123705), filed with the SEC on March 31, 2005.
  *5.1
  Opinion of Jay McNamara, Esq, Senior Counsel, Corporate & Finance,
  of the Company.
  *23.1
  Consent of BDO Seidman, LLP.
  *23.2
  Consent of PricewaterhouseCoopers LLP, Independent Registered
  Public Accounting Firm.
  *23.3
  Consent of Ernst & Young LLP, Independent Registered Public
  Accounting Firm.
  *23.4
  Consent of Colby & Company, PLC.
  Table of Contents
  Exhibit
  Number
  Description
  23.5
  Consent of Jay McNamara, Esq., Senior Counsel, Corporate &
  Finance, of the Company (included in Exhibit 5.1).
  24.1
  Power of attorney (contained on the signature page to this
  registration statement).
  *
  Filed herewith.